Which medication requires reporting shortness of breath as a potential adverse effect?

Which medication requires reporting shortness of breath as a potential adverse effect?

• A. Hydroxychloroquine
• B. Infliximab
• C. Methotrexate
• D. Ephedrine

Answer: (B)

Shortness of breath signals a possible infusion-related reaction to infliximab, a monoclonal antibody used for autoimmune diseases. Because these reactions can occur during or after the IV infusion and may progress to more serious events like anaphylaxis, reporting new or worsening dyspnea right away is essential so the infusion can be paused and appropriate treatment started. While other medications have their own adverse effects, infliximab carries a notable risk of infusion-related respiratory symptoms, making SOB a key side effect to monitor and report.

Shortness of breath signals a possible infusion-related reaction to infliximab, a monoclonal antibody used for autoimmune diseases. Because these reactions can occur during or after the IV infusion and may progress to more serious events like anaphylaxis, reporting new or worsening dyspnea right away is essential so the infusion can be paused and appropriate treatment started. While other medications have their own adverse effects, infliximab carries a notable risk of infusion-related respiratory symptoms, making SOB a key side effect to monitor and report.